# OnCo record frontmind (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/frontmind/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "frontmind", "NCT04824092" ;
  schema:name "frontMIND"@en ;
  schema:description "The first frontline regimen to beat R-CHOP in high-risk large B-cell lymphoma since rituximab, by adding a CD19 antibody and lenalidomide."@en ;
  schema:url <https://onco.cc/trials/frontmind/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04824092>, <https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00866-4/fulltext> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2021-05-11" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/tafasitamab/>, <https://onco.cc/drugs/lenalidomide/> ;
  onco:companies <https://onco.cc/companies/incyte/> ;
  onco:terms <https://onco.cc/terms/ipi-score/> .